Improving Pneumococcal Vaccination Rates in Patients With Diabetes

Shea KM Edelsberg J Weycker D Farkouh RA Strutton DR Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1(1):ofu024.

Torres A Blasi F Dartois N Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70:984-989.

Matanock A Lee G Gierke R Kobayashi M Leidner A Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years. MMWR Morb Mortal Wkly Rep. 2019;68:1069-1075.

Villarroel MA Vahration A. Vaccination Coverage Among Adults with Diagnosed Diabetes: United States, 2015. NCHS Data Brief, No. 265. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 2016.